Delivery Order SPE2DR25D1002-SPE2DR26FGK2C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $40,527.81 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, was competitively awarded without any set-aside designation. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99...
- The Defense Logistics Agency awarded a $21,479.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This is a non-set-aside competitive award with an ultimate completion date of November 5, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be performed from the contractor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,017.61 on November 5, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract utilizes firm fixed pricing with no set-aside designation and is expected to be completed by November 6, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated...
- The Defense Logistics Agency awarded a $4,667.05 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $44,398.54 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This competitive, firm fixed-price contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency's Medical Supply Chain awarded a $41,519.06 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price, non-set-aside contract is expected to be completed by September 22, 2025, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to reduce LDL cholesterol levels and is essential for...
- The Defense Logistics Agency awarded a delivery order valued at $33,388.01 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance completion by December 2, 2025. This non-set-aside, firm fixed-price delivery order was issued on December 1, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $34,885.30 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with completion scheduled for November 6, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Repatha is a prescription medication used to treat high cholesterol, and the SureClick...
- The Defense Logistics Agency awarded a $29,995.79 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.46 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of July 14, 2025. This firm fixed price, competitively awarded contract was issued without a set-aside designation and is being fulfilled from the vendor's place of business in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGK2CDelivery Order
The Defense Logistics Agency awarded a $4,971.89 delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The non-set-aside, firm fixed price contract is a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. This prime contract vehicle supports comprehensive pharmaceutical and medical supply requirements across military healthcare systems and related federal agencies worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates capability across diverse therapeutic domains, including specialty medications, brand-name and generic pharmaceuticals, and medical devices. The delivery of Repatha—a cardiovascular medication indicated for cholesterol management—reflects AmerisourceBergen's role as a key supplier of specialty pharmaceutical products within the military supply chain, with performance expected by November 25, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/23/25 |